Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone.

Tumour-inhibitory effects of a new antagonist of growth hormone-releasing hormone (GH-RH), MZ-4-71, were evaluated in nude mice bearing androgen-independent human prostate cancer cell lines DU-145 and PC-3 and in Copenhagen rats implanted with Dunning R-3327 AT-1 prostatic adenocarcinoma. After 6 we...

Descripción completa

Detalles Bibliográficos
Autores principales: Jungwirth, A., Schally, A. V., Pinski, J., Halmos, G., Groot, K., Armatis, P., Vadillo-Buenfil, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223520/
https://www.ncbi.nlm.nih.gov/pubmed/9184172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223520/
https://www.ncbi.nlm.nih.gov/pubmed/9184172

Ejemplares similares